Global Histone Methyltransferase Market Size To Exceed USD 533.2 Million By 2035 | CAGR Of 5.21%
Category: HealthcareGlobal Histone Methyltransferase Market Size To Exceed USD 533.2 Million By 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global Histone Methyltransferase Market Size is Expected to Grow from USD 305.0 Million in 2024 to USD 533.2 Million by 2035, at a CAGR of 5.21% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 300 pages with 101 Market data tables and figures & charts from the report on the "Global Histone Methyltransferase Market Size, Share, and COVID-19 Impact Analysis, By Type (EZ, SET1, SET2, SMYD, SUV39, SUV4-20, and RIZ), By Application (Lung Cancer, Liver Cancer, Breast Cancer, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/histone-methyltransferase-market
The Histone Methyltransferase Market Size is the commercial landscape surrounding enzymes catalysing the addition of methyl groups to histone proteins, which is a crucial epigenetic modification regulating gene expression. Histone methyltransferases are histone-modifying enzymes playing a vital role in epigenetics, specifically by catalysing the transfer of methyl groups to histone proteins. Advancements in next-generation sequencing and bioinformatics for enabling more precise mapping of histone modifications are creating new market growth opportunities for histone methyltransferase. The growing prevalence of cancer is responsible for driving the market demand as histone methyltransferase plays a crucial role in the development of new and more effective drugs, as a possible therapeutic target. Increasing research and development activities emphasizing cancer therapies, along with an increasing demand for personalized medicine, are contributing to the market growth. However, the increased R&D costs, strict regulatory requirements, and supply chain disruptions are challenging the market growth.
The SMYD segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the type, the histone methyltransferase market is divided into EZ, SET1, SET2, SMYD, SUV39, SUV4-20, and RIZ. Among these, the SMYD segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period. SMYD protein is involved in various biological processes for applications including muscle development, cancer, and immune response.
The breast cancer segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the histone methyltransferase market is divided into lung cancer, liver cancer, breast cancer, and others. Among these, the breast cancer segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. In breast cancer treatment, histone methyltransferase aids in maintaining genomic stability, transcription, DNA repair, and modulating chromatin in cancer cells.
North America is expected to hold the majority share of the global histone methyltransferase market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global histone methyltransferase market during the forecast period. The high investment in cancer treatment, with an increased prevalence rate of cancer disease, is expected to propel the market demand for histone methyltransferase. Further, an increase in research activities associated with epigenetics and cancer therapies is driving the histone methyltransferase market.
Asia Pacific is anticipated to grow at the fastest pace in the global histone methyltransferase market during the forecast period. An increasing prevalence of cancer, including lung and liver cancer, as well as upsurging cancer treatment awareness contributing to driving the market demand. Additionally, an increasing technological development in the epigenetics field is contributing to propelling the market growth.
Europe is anticipated to hold a significant share of the histone methyltransferase market during the projected timeframe. Emergence of epigenetics for the study of changes in gene expression in cancer diagnosis, contributing to driving the histone methyltransferase market. Further, the growing application of histone methyltransferase as a biomarker in the diagnosis of cancer is propelling the market growth.
Major vendors in the global histone methyltransferase market are Diagenode, Inc., Cell Signaling Technology, Inc., Cayman Chemical Company, Constellation Pharmaceuticals, CELLCENTRIC LIMITED, Sequenom, Inc., Bellbrook Labs, Merck KGaA, Active motif, Inc., Thermo Fisher Scientific Inc., Epizyme, Inc., Sigma-Aldrich Corporation, Ribomed Biotechnologies, Inc., Boehringer Ingelheim group, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2021, Boehringer Ingelheim announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology research to develop the next generation of precision medicines designed to revolutionize cancer treatments.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the histone methyltransferase market based on the below-mentioned segments:
Global Histone Methyltransferase Market, By Type
- EZ
- SET1
- SET2
- SMYD
- SUV39
- SUV4-20
- RIZ
Global Histone Methyltransferase Market, By Application
- Lung Cancer
- Liver Cancer
- Breast Cancer
- Others
Global Histone Methyltransferase Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?